EURETINA 2023: Safety and efficacy through week 48 in the Phase 2a STARLIGHT clinical trial

News
Article
Conference|EURETINA

We spoke with Michael Singer, MD who provided an overview of his presentation, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial"

The 23rd annual EURETINA Congress is underway in Amsterdam, the Netherlands. We spoke with Michael Singer, MD who provided an overview of his presentation, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial."

Here's what he had to say about the meeting and his research.

Audio Transcript

Editor's note - This transcript has been edited for clarity.

Related Videos
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Esen K. Akpek, MD, Professor at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, converses via zoom with David Hutton of Ophthalmology Times
Related Content
A physician uses a stylus to look at the image of a cornea. Image credit: ©warloka79 – stock.adobe.com

Why the future of ophthalmology is in corneal grafts

December 6th 2023
Article

Restoration and regeneration represent a new paradigm

A patient covers her eye to perform a Snellen chart test as the optometrist looks on. Image credit: ©megaflopp – stock.adobe.com

New research data reflect patient satisfaction following faricimab treat-and-extend regimen

December 5th 2023
Article

A retrospective observational study shows BCVA was maintained after 6 months for patients with neovascular AMD

An optometrist examines an elderly patient's eyes. Image credit: ©Nadia L/peopleimages.com – stock.adobe.com

Prevent Blindness participates in first-ever World Geographic Atrophy Day

December 5th 2023
Article

In recognition of global Geographic Atrophy Week, Prevent Blindness is providing free educational resources on GA for patients, care partners and healthcare professionals

An eyeball with a view of the globe imposed on the iris. Image credit: ©Chris Tefme – stock.adobe.com

A global view of diabetic eye disease

December 4th 2023
Article

At this year’s EURETINA meeting, retina specialists highlighted important developments in diabetic macular oedema and diabetic retinopathy research

A DNA double-helix is captioned, "Infiltrating the retina: a new study on gene therapy for LHON"

Cellular evidence of retinal ganglion cell transfection after LHON treatment

December 1st 2023
Article

Data show transfection in both eyes despite unilateral injection

Rob Thornhill, CEO, Centricity Vision, at AAO 2023

AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill

November 28th 2023
Article

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

© 2023 MJH Life Sciences

All rights reserved.